Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Qiu-Ling Ma"'
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-6 (2018)
Abstract Background MicroRNAs are of special interest in cancer research and hold significant promise as diagnostic and prognostic biomarkers for malignant disease. MiR-362-5p have been found to exert both oncogenic and tumor suppressive effects depe
Externí odkaz:
https://doaj.org/article/b81c98796ad649749d83611ed8748181
Autor:
Jing-Han Wang, Qi Guo, Zhi-Xin Ma, Qiu-Ling Ma, Meng-Xia Yu, Xiu-Feng Yin, Sha-Sha Lu, Hong-Qiong Xie, Yue-Hong Jiang, Dan Shen, Li-Ya Ma, Hui Shi, Wen-Juan Yu, Ye-Jiang Lou, Ying Li, Min Yang, Gai-Xiang Xu, Li-Ping Mao, Jian-Hu Li, Huan-Ping Wang, Dong-Mei Wang, Ju-Ying Wei, Hong-Yan Tong, Jian Huang, Jie Jin
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0140622 (2015)
The effect of time from diagnosis to treatment (TDT) on overall survival of patients with acute myeloid leukemia (AML) remains obscure. Furthermore, whether chemotherapy delay impacts overall survival (OS) of patients with a special molecular subtype
Externí odkaz:
https://doaj.org/article/c440f2105e534cc4b0cceff4929c394d
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-9 (2019)
Journal of Translational Medicine
Journal of Translational Medicine
Background Aberrant metabolism is a hallmark of cancer cells. Recently, ATP citrate-lyase (ACLY) expression was demonstrated as an independent predictor of clinical outcome in solid tumors. However, no systematic study was conducted to explore the pr
Autor:
Zhixin Ma, Mengxia Yu, Wenbin Qian, Hongyan Tong, Qi Guo, Xiufeng Yin, Hanzhang Pan, Qiu-Ling Ma, Yungui Wang, Jiansong Huang, Jie Jin, Chao Hu, Xia Li, Jinghan Wang, Haitao Meng, Dongmei Wang
Publikováno v:
Scientific Reports
Huntingtin interacting protein 1 (HIP1) is an endocytic protein which is overexpressed in a variety of human cancers and involved in cancer-causing translocation in leukemia. However, the prognostic impact of HIP1 expression on AML remains unclear. I
Autor:
Qiu-Ling, Ma, Jing-Han, Wang, Yun-Gui, Wang, Chao, Hu, Qi-Tian, Mu, Meng-Xia, Yu, Lei, Wang, Dong-Mei, Wang, Min, Yang, Xiu-Feng, Yin, Fei-Fei, Chen, Sha-Sha, Lu, Jian, Chen, Zhi-Juan, Zhu, Sai-Juan, Chen, Jie, Jin
Publikováno v:
International journal of cancer. 137(5)
The prognostic value of IDH1 mutations has been systematically evaluated in acute myeloid leukemia (AML) patients recently. However, the role of IDH1 expression in AML is still under exploration. To investigate the clinical significance, we analyzed
Autor:
Hong-yan, Tong, Chao, Hu, Meng-xia, Yu, Qiu-ling, Ma, Fei-fei, Chen, Li, Ye, Ju-ying, Wei, Gai-xiang, Xu, Li-ping, Mao, Ying, Li, Jie, Jin
Publikováno v:
Zhonghua yi xue za zhi. 93(40)
To assess the prevalence and clinical characteristics of isocitrate dehydrogenase 1 and 2 (IDH 1 and IDH2) gene mutations in myelodysplastic syndrome (MDS) patients.Pretreatment bone marrow specimens were enriched for mononuclear cells in 108 adult p
Publikováno v:
Molecular medicine reports. 9(3)
Cell differentiation agent II (CDA‑II) is a DNA methyltransferase inhibitor isolated from healthy human urine. In the present study, the antitumor activity of CDA‑II on human multiple myeloma (MM) cell lines via the mitochondrial pathway was firs
Publikováno v:
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. 33(5)
To explore the effect of ITF2357, a novel histone deacetylase (HDAC) inhibitor, on the growth, differentiation and apoptosis of acute myeloid leukemic (AML) cells and its mechanism.AML cell lines kasumi-1 cells as a model for AML1-ETO positive, and T
Publikováno v:
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. 33(4)
To analyze the expressed mRNA of the factor subunit A (FA) in monocyte in a hereditary factor (F) deficiency family.The F A mRNA of the proband and the other family members was analyzed by RT-PCR, semi-quantitative RT-PCR, cloning and sequencing. The
Publikováno v:
Leukemialymphoma. 50(5)
Glucocorticoids are widely used chemotherapeutic agents for multiple myeloma. Drug resistance to steroid therapies is associated with the downregulation or loss of glucocorticoid receptor expression in malignant plasma cells. In this study, we examin